David Lubner

Insider Reports History

Location
C/O Tetraphase Pharmaceuticals, Inc., 480 Arsenal Street, Suite 110, Watertown, MA
Signature
/s/ Halley Gilbert, as attorney-in-fact for David Lubner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Lubner:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Dyne Therapeutics, Inc. Director Stock option (right to buy) 35K May 30, 2025 Direct
Vor Biopharma Inc. Director Stock Option (Right to Buy) 30K May 22, 2025 Direct
Arcellx, Inc. Director Stock Option (right to buy) 9.17K May 29, 2025 Direct
CRESCENT BIOPHARMA, INC. Director Stock Option (Right to Buy) 9.02K Jun 23, 2025 Direct
CARGO Therapeutics, Inc. Director Stock Option (Right to Buy) 0 Aug 19, 2025 Direct
Gemini Therapeutics, Inc. /DE Director Stock Option (Right to Buy) 0 Oct 4, 2021 Direct
POINT Biopharma Global Inc. Director Common Stock 0 $12.45 Dec 27, 2023 Direct
POINT Biopharma Global Inc. Director Stock Option (Right to Buy) 0 Dec 27, 2023 Direct

Insider Reports Filed by David Lubner

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRGX CARGO Therapeutics, Inc. Aug 19, 2025 1 $0 4 Aug 19, 2025 Director
CBIO GLYCOMIMETICS INC Jun 23, 2025 1 $0 4 Jun 23, 2025 Director
CRGX CARGO Therapeutics, Inc. Jun 18, 2025 1 $0 4 Jun 20, 2025 Director
CBIO GLYCOMIMETICS INC Jun 13, 2025 0 $0 3 Jun 23, 2025 Director
DYN Dyne Therapeutics, Inc. May 30, 2025 1 $0 4 Jun 3, 2025 Director
ACLX Arcellx, Inc. May 29, 2025 1 $0 4 May 30, 2025 Director
VOR Vor Biopharma Inc. May 22, 2025 1 $0 4 May 23, 2025 Director
CRGX CARGO Therapeutics, Inc. Jun 4, 2024 1 $0 4 Jun 6, 2024 Director
ACLX Arcellx, Inc. May 28, 2024 1 $0 4 Jun 6, 2024 Director
VOR Vor Biopharma Inc. May 23, 2024 1 $0 4 May 28, 2024 Director
DYN Dyne Therapeutics, Inc. May 22, 2024 1 $0 4 May 24, 2024 Director
PNT POINT Biopharma Global Inc. Dec 26, 2023 5 $0 4 Dec 27, 2023 Director
CRGX CARGO Therapeutics, Inc. Nov 9, 2023 1 $0 4 Nov 13, 2023 Director
CRGX CARGO Therapeutics, Inc. Nov 9, 2023 0 $0 3 Nov 9, 2023 Director
ACLX Arcellx, Inc. Jun 14, 2023 1 $0 4 Jun 16, 2023 Director
PNT POINT Biopharma Global Inc. Jun 1, 2023 1 $0 4 Jun 5, 2023 Director
VOR Vor Biopharma Inc. May 26, 2023 1 $0 4 Jun 2, 2023 Director
DYN Dyne Therapeutics, Inc. May 24, 2023 1 $0 4 May 25, 2023 Director
PNT POINT Biopharma Global Inc. Nov 23, 2022 1 $24.7K 4 Nov 28, 2022 Director
DYN Dyne Therapeutics, Inc. Jul 5, 2022 1 $0 4 Jul 6, 2022 Director
VOR Vor Biopharma Inc. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director
DYN Dyne Therapeutics, Inc. Jun 3, 2022 1 $0 4 Jun 6, 2022 Director
PNT POINT Biopharma Global Inc. Jun 2, 2022 1 $0 4 Jun 6, 2022 Director
ACLX Arcellx, Inc. Feb 8, 2022 2 $0 4 Feb 9, 2022 Director
ACLX Arcellx, Inc. Feb 3, 2022 1 $0 4 Feb 7, 2022 Director
ACLX Arcellx, Inc. Feb 3, 2022 0 $0 3 Feb 3, 2022 Director
IRON Gemini Therapeutics, Inc. /DE Oct 4, 2021 1 $0 4/A Mar 9, 2022 Director
PNT POINT Biopharma Global Inc. Jul 6, 2021 1 $0 4 Jul 8, 2021 Director
DYN Dyne Therapeutics, Inc. May 26, 2021 1 $0 4 May 27, 2021 Director
IRON Gemini Therapeutics, Inc. /DE Mar 12, 2021 1 $0 4/A Mar 9, 2022 Director